| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Financial Officer
2 companies
Hastings David C is a Chief Financial Officer at Arbutus Biopharma Corp with holdings across 2 companies. Recent SEC Form 4 filings include 2 buys and 2 sells.
Estimated insider holdings value: $1.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 4, 2025 | ABUS Arbutus Biopharma Corp | Chief Financial Officer | Sell | 22,183 | $3.28 | $72,826.79 | -12.2% | +4.5% | +15.5% | |
| Feb 2, 2024 | ABUS Arbutus Biopharma Corp | Chief Financial Officer | Sell | 9,593 | $2.31 | $22,183.81 | -5.0% | +12.6% | +39.9% | |
| Mar 8, 2018 | SCYX Scynexis Inc | Director | Buy | 11,834 | $1.69 | $19,999.46 | +59.2% | - | - | |
| Jun 21, 2017 | SCYX Scynexis Inc | Director | Buy | 20,000 | $1.75 | $35,000.00 | New | - | - |